{"pmid":32151674,"title":"Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer.","text":["Duration of quarantine in hospitalized patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: a question needing an answer.","J Hosp Infect","Lombardi, Andrea","Bozzi, Giorgio","Mangioni, Davide","Muscatello, Antonio","Peri, Anna Maria","Taramasso, Lucia","Ungaro, Riccardo","Bandera, Alessandra","Gori, Andrea","32151674"],"journal":"J Hosp Infect","authors":["Lombardi, Andrea","Bozzi, Giorgio","Mangioni, Davide","Muscatello, Antonio","Peri, Anna Maria","Taramasso, Lucia","Ungaro, Riccardo","Bandera, Alessandra","Gori, Andrea"],"date":"2020-03-11T11:00:00Z","year":2020,"_id":"32151674","week":"202011|Mar 09 - Mar 15","doi":"10.1016/j.jhin.2020.03.003","keywords":["COVID-19","SARS-CoV-2","nosocomial transmission","quarantine"],"source":"PubMed","topics":["Transmission"],"weight":1,"_version_":1661359647830835200,"score":6.7365713,"similar":[{"pmid":32134381,"title":"Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China.","text":["Lack of Vertical Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, China.","A woman with 2019 novel coronavirus disease in her 35th week of pregnancy delivered an infant by cesarean section in a negative-pressure operating room. The infant was negative for severe acute respiratory coronavirus 2. This case suggests that mother-to-child transmission is unlikely for this virus.","Emerg Infect Dis","Li, Yang","Zhao, Ruihong","Zheng, Shufa","Chen, Xu","Wang, Jinxi","Sheng, Xiaoli","Zhou, Jianying","Cai, Hongliu","Fang, Qiang","Yu, Fei","Fan, Jian","Xu, Kaijin","Chen, Yu","Sheng, Jifang","32134381"],"abstract":["A woman with 2019 novel coronavirus disease in her 35th week of pregnancy delivered an infant by cesarean section in a negative-pressure operating room. The infant was negative for severe acute respiratory coronavirus 2. This case suggests that mother-to-child transmission is unlikely for this virus."],"journal":"Emerg Infect Dis","authors":["Li, Yang","Zhao, Ruihong","Zheng, Shufa","Chen, Xu","Wang, Jinxi","Sheng, Xiaoli","Zhou, Jianying","Cai, Hongliu","Fang, Qiang","Yu, Fei","Fan, Jian","Xu, Kaijin","Chen, Yu","Sheng, Jifang"],"date":"2020-03-06T11:00:00Z","year":2020,"_id":"32134381","week":"202010|Mar 02 - Mar 08","doi":"10.3201/eid2606.200287","keywords":["2019 novel coronavirus disease","COVID-19","China","SARS-CoV-2","Severe acute respiratory syndrome coronavirus 2","coronaviruses","pregnancy","respiratory infections","vertical transmission","viruses"],"source":"PubMed","locations":["China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Case Report","Transmission"],"weight":1,"_version_":1661359647695568896,"score":66.03432},{"pmid":32125269,"title":"Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020.","text":["Community Transmission of Severe Acute Respiratory Syndrome Coronavirus 2, Shenzhen, China, 2020.","Since early January 2020, after the outbreak of 2019 novel coronavirus infection in Wuhan, China, approximately 365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed.","Emerg Infect Dis","Liu, Jiaye","Liao, Xuejiao","Qian, Shen","Yuan, Jing","Wang, Fuxiang","Liu, Yingxia","Wang, Zhaoqin","Wang, Fu-Sheng","Liu, Lei","Zhang, Zheng","32125269"],"abstract":["Since early January 2020, after the outbreak of 2019 novel coronavirus infection in Wuhan, China, approximately 365 confirmed cases have been reported in Shenzhen, China. The mode of community and intrafamily transmission is threatening residents in Shenzhen. Strategies to strengthen prevention and interruption of these transmissions should be urgently addressed."],"journal":"Emerg Infect Dis","authors":["Liu, Jiaye","Liao, Xuejiao","Qian, Shen","Yuan, Jing","Wang, Fuxiang","Liu, Yingxia","Wang, Zhaoqin","Wang, Fu-Sheng","Liu, Lei","Zhang, Zheng"],"date":"2020-03-04T11:00:00Z","year":2020,"_id":"32125269","week":"202010|Mar 02 - Mar 08","doi":"10.3201/eid2606.200239","keywords":["2019 novel coronavirus","COVID-19","China","SARS-CoV-2","Shenzhen","community transmission","coronavirus","epidemiologic","respiratory infections","severe respiratory syndrome coronavirus 2","viruses"],"source":"PubMed","locations":["Shenzhen","Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Case Report"],"weight":1,"_version_":1661359647622168576,"score":64.36841},{"pmid":32170027,"title":"Trainees and covid-19: your questions answered.","text":["Trainees and covid-19: your questions answered.","BMJ","Rimmer, Abi","32170027"],"journal":"BMJ","authors":["Rimmer, Abi"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170027","week":"202011|Mar 09 - Mar 15","doi":"10.1136/bmj.m1059","source":"PubMed","topics":["General Info"],"weight":1,"_version_":1661359647913672704,"score":61.31582},{"pmid":32102279,"title":"Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19).","text":["Assessing the Impact of Reduced Travel on Exportation Dynamics of Novel Coronavirus Infection (COVID-19).","The impact of the drastic reduction in travel volume within mainland China in January and February 2020 was quantified with respect to reports of novel coronavirus (COVID-19) infections outside China. Data on confirmed cases diagnosed outside China were analyzed using statistical models to estimate the impact of travel reduction on three epidemiological outcome measures: (i) the number of exported cases, (ii) the probability of a major epidemic, and (iii) the time delay to a major epidemic. From 28 January to 7 February 2020, we estimated that 226 exported cases (95% confidence interval: 86,449) were prevented, corresponding to a 70.4% reduction in incidence compared to the counterfactual scenario. The reduced probability of a major epidemic ranged from 7% to 20% in Japan, which resulted in a median time delay to a major epidemic of two days. Depending on the scenario, the estimated delay may be less than one day. As the delay is small, the decision to control travel volume through restrictions on freedom of movement should be balanced between the resulting estimated epidemiological impact and predicted economic fallout.","J Clin Med","Anzai, Asami","Kobayashi, Tetsuro","Linton, Natalie M","Kinoshita, Ryo","Hayashi, Katsuma","Suzuki, Ayako","Yang, Yichi","Jung, Sung-Mok","Miyama, Takeshi","Akhmetzhanov, Andrei R","Nishiura, Hiroshi","32102279"],"abstract":["The impact of the drastic reduction in travel volume within mainland China in January and February 2020 was quantified with respect to reports of novel coronavirus (COVID-19) infections outside China. Data on confirmed cases diagnosed outside China were analyzed using statistical models to estimate the impact of travel reduction on three epidemiological outcome measures: (i) the number of exported cases, (ii) the probability of a major epidemic, and (iii) the time delay to a major epidemic. From 28 January to 7 February 2020, we estimated that 226 exported cases (95% confidence interval: 86,449) were prevented, corresponding to a 70.4% reduction in incidence compared to the counterfactual scenario. The reduced probability of a major epidemic ranged from 7% to 20% in Japan, which resulted in a median time delay to a major epidemic of two days. Depending on the scenario, the estimated delay may be less than one day. As the delay is small, the decision to control travel volume through restrictions on freedom of movement should be balanced between the resulting estimated epidemiological impact and predicted economic fallout."],"journal":"J Clin Med","authors":["Anzai, Asami","Kobayashi, Tetsuro","Linton, Natalie M","Kinoshita, Ryo","Hayashi, Katsuma","Suzuki, Ayako","Yang, Yichi","Jung, Sung-Mok","Miyama, Takeshi","Akhmetzhanov, Andrei R","Nishiura, Hiroshi"],"date":"2020-02-28T11:00:00Z","year":2020,"_id":"32102279","week":"20209|Feb 24 - Mar 01","doi":"10.3390/jcm9020601","keywords":["emerging infectious diseases","imported case","migration","quarantine","travel"],"source":"PubMed","locations":["Japan","China"],"countries":["Japan","China"],"countries_codes":["JPN|Japan","CHN|China"],"topics":["Transmission"],"weight":1,"_version_":1661359647539331073,"score":60.433582},{"pmid":32172672,"title":"A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","text":["A tug-of-war between severe acute respiratory syndrome coronavirus 2 and host antiviral defence: lessons from other pathogenic viruses.","World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed.","Emerg Microbes Infect","Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan","32172672"],"abstract":["World Health Organization has declared the ongoing outbreak of coronavirus disease 2019 (COVID-19) a Public Health Emergency of International Concern. The virus was named severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by the International Committee on Taxonomy of Viruses. Human infection with SARS-CoV-2 leads to a wide range of clinical manifestations ranging from asymptomatic, mild, moderate to severe. The severe cases present with pneumonia, which can progress to acute respiratory distress syndrome. The outbreak provides an opportunity for real-time tracking of an animal coronavirus that has just crossed species barrier to infect humans. The outcome of SARS-CoV-2 infection is largely determined by virus-host interaction. Here, we review the discovery, zoonotic origin, animal hosts, transmissibility and pathogenicity of SARS-CoV-2 in relation to its interplay with host antiviral defense. A comparison with SARS-CoV, Middle East respiratory syndrome coronavirus, community-acquired human coronaviruses and other pathogenic viruses including human immunodeficiency viruses is made. We summarize current understanding of the induction of a proinflammatory cytokine storm by other highly pathogenic human coronaviruses, their adaptation to humans and their usurpation of the cell death programmes. Important questions concerning the interaction between SARS-CoV-2 and host antiviral defence, including asymptomatic and presymptomatic virus shedding, are also discussed."],"journal":"Emerg Microbes Infect","authors":["Fung, Sin-Yee","Yuen, Kit-San","Ye, Zi-Wei","Chan, Chi-Ping","Jin, Dong-Yan"],"date":"2020-03-17T11:00:00Z","year":2020,"_id":"32172672","week":"202012|Mar 16 - Mar 22","doi":"10.1080/22221751.2020.1736644","keywords":["2019 novel coronavirus","COVID-19","Coronavirus","SARS-CoV","SARS-CoV-2","host antiviral response","type I interferon"],"source":"PubMed","topics":["Mechanism","Transmission"],"weight":1,"_version_":1661456248821776385,"score":60.149002}]}